Immune suppression by myeloid-derived suppressor cells, MDSCs, in MYCN-driven neuroblastoma provides a potential target for cancer immunotherapy
Nina Eissler, Baldur Sveinbjörnsson, Anna Kock, John Inge Johnsen, Per Kogner
Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P203; DOI: 10.1186/2051-1426-2-S3-P203